Osiris Therapeutics Reports Fourth Quarter and Full Year 2008 … – Phramalive.com
COLUMBIA, Md.–(BUSINESS WIRE)–Feb 27, 2009 – Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular and …
[Read the full article here]Related News:
Osiris Therapeutics to Present at Barclays Capital Global Healthcare … – PR Inside
Osiris Therapeutics to Present at Piper Jaffray Conference
BioTime to form Asian subsidiary for stem cell products